ursodeoxycholic acid has been researched along with Colitis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; He, Z; Li, S; Liu, S; Ma, Y; Wang, W; Wang, Y; Xiao, J; Yang, H; Yang, S; Zhang, S | 1 |
| Li, W; Liu, X; Liuqi, S; Peng, B; Wang, J; Wang, S; Yin, J; Zhang, B; Zhang, Y | 1 |
| Bai, Y; Han, D; Jia, W; Li, D; Lian, S; Lu, D; Ni, D; Pi, Y; Tao, S; Wang, J; Wang, Z; Wu, Y; Ye, H; Zhang, G; Zhang, S; Zhang, X; Zhao, J; Zheng, X; Zou, X | 1 |
| Chu, FH; Dai, ZQ; Gao, F; Gao, S; Jiang, XQ; Kong, JW; Lei, HM; Li, SL; Lu, MJ; Wang, ZJ; Xu, B; Xu, SJ; Zheng, HC | 1 |
| Benninga, MA; Beuers, UH; Plötz, FB; Rademaker, AA | 1 |
| Abdollahi, M; Baeeri, M; Esmaily, H; Miroliaee, AE; Vaziri-Bami, A | 1 |
| Fabris, L; Fiorotto, R; Hoque, R; Scirpo, R; Spirli, C; Strazzabosco, M; Trauner, M | 1 |
| Bayat, A; Larsen, EP; Vyberg, M | 1 |
| Cao, M; Hanski, C; Hanski, ML; Jahreis, G; Keller, S; Loddenkemper, C; Stein, H; Zeitz, M | 1 |
| Kloeters-Plachky, P; Rost, D; Rudolph, G; Stiehl, A | 1 |
| Kohno, H; Miyamoto, S; Suzuki, R; Tanaka, T; Wakabayashi, K; Yasui, Y | 1 |
| Bernard, O; Brousse, N; Canioni, D; Fabre, M; Lacaille, F; Schmitz, J | 1 |
| Arndt, H; Gross, V; Kullmann, F; Rüschoff, J; Schölmerich, J | 1 |
1 review(s) available for ursodeoxycholic acid and Colitis
| Article | Year |
|---|---|
Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature.
Topics: Bile Ducts; Biomarkers; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Colitis; Colonoscopy; Crohn Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
12 other study(ies) available for ursodeoxycholic acid and Colitis
| Article | Year |
|---|---|
Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum β-lactamase-producing enteroaggregative Escherichia coli infection.
Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Caco-2 Cells; Cattle; Colitis; Diarrhea; Escherichia coli; Escherichia coli Infections; Gastrointestinal Microbiome; Homeostasis; Humans; Mice; Sepsis; Ursodeoxycholic Acid | 2022 |
Fucoidan Ameliorated Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating Gut Microbiota and Bile Acid Metabolism.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2022 |
Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization.
Topics: Animals; Birth Weight; Colitis; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Mice; Swine; Ursodeoxycholic Acid | 2023 |
[Therapeutic effect of ursodeoxycholic acid-berberine supramolecular nanoparticles on ulcerative colitis based on supramolecular system induced by weak bond].
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Drugs, Chinese Herbal; Interleukin-6; Mice; Nanoparticles; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2023 |
[A child with primary sclerosing cholangitis].
Topics: Abdominal Pain; Child; Cholangitis, Sclerosing; Colitis; Diagnosis, Differential; Glucocorticoids; Humans; Male; Ursodeoxycholic Acid | 2015 |
The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
Topics: Animals; Antioxidants; Cholagogues and Choleretics; Colitis; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Male; NF-kappa B; Rats; Rats, Wistar; Silybin; Silymarin; Trinitrobenzenesulfonic Acid; Ursodeoxycholic Acid | 2011 |
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
Topics: Animals; Anti-Bacterial Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; HEK293 Cells; Humans; Immunity, Innate; Inflammation Mediators; Keratin-19; Leukocyte Common Antigens; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Neomycin; NF-kappa B; Phosphorylation; Polymyxin B; src-Family Kinases; Time Factors; Toll-Like Receptor 4; Transfection; Ursodeoxycholic Acid | 2011 |
Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
Topics: Administration, Oral; Animals; Bile Acids and Salts; Carcinoma; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Colitis; Colon; Colorectal Neoplasms; Diet; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2006 |
Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
Topics: Adult; Bile Acids and Salts; Case-Control Studies; Cholangitis, Sclerosing; Colitis; Colonic Pouches; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Probability; Reference Values; Risk Assessment; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase 2; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; RNA, Messenger; Sulfasalazine; Ursodeoxycholic Acid | 2007 |
Celiac disease, inflammatory colitis, and primary sclerosing cholangitis in a girl with Turner's syndrome.
Topics: Biopsy; Celiac Disease; Child; Cholangitis, Sclerosing; Colitis; Female; Glutens; Hormones; Humans; Intestinal Mucosa; Jejunum; Sulfasalazine; Turner Syndrome; Ursodeoxycholic Acid | 1995 |
Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
Topics: Animals; Body Weight; Colitis; Intestinal Mucosa; Male; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors; Trinitrobenzenesulfonic Acid; Ursodeoxycholic Acid | 1997 |